Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent

ZP1 FBN2

4.59e-03188112GO:0005201
GeneOntologyMolecularFunctionantigen binding

IGLV7-43 IGLV6-57

4.68e-03190112GO:0003823
GeneOntologyMolecularFunctionstructural molecule activity

ZP1 FBN2 KRT38

1.12e-02891113GO:0005198
GeneOntologyCellularComponentcollagen-containing extracellular matrix

ZP1 USH2A FBN2

2.30e-03530113GO:0062023
GeneOntologyCellularComponentimmunoglobulin complex

IGLV7-43 IGLV6-57

3.29e-03166112GO:0019814
GeneOntologyCellularComponentextracellular matrix

ZP1 USH2A FBN2

4.20e-03656113GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

ZP1 USH2A FBN2

4.24e-03658113GO:0030312
DomainEGF_1

USH2A FBN2

6.27e-0325592PS00022
PathwayWP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE

TGFBR1 FBN2

1.08e-042592M39713
PathwayREACTOME_CD22_MEDIATED_BCR_REGULATION

IGLV7-43 IGLV6-57

6.50e-046192M27581
PathwayREACTOME_FCGR_ACTIVATION

IGLV7-43 IGLV6-57

8.31e-046992M27108
PathwayREACTOME_SCAVENGING_OF_HEME_FROM_PLASMA

IGLV7-43 IGLV6-57

8.31e-046992M27150
PathwayREACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS

IGLV7-43 IGLV6-57

8.80e-047192M1078
PathwayREACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION

IGLV7-43 IGLV6-57

8.80e-047192M27203
PathwayREACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT

IGLV7-43 IGLV6-57

1.12e-038092M6121
PathwayREACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS

IGLV7-43 IGLV6-57

1.17e-038292M27110
PathwayREACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS

IGLV7-43 IGLV6-57

1.29e-038692M601
PathwayREACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION

IGLV7-43 IGLV6-57

1.29e-038692M27206
PathwayREACTOME_FCERI_MEDIATED_MAPK_ACTIVATION

IGLV7-43 IGLV6-57

1.32e-038792M27205
PathwayREACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS

IGLV7-43 IGLV6-57

1.57e-039592M29842
PathwayREACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS

IGLV7-43 IGLV6-57

1.67e-039892M27152
PathwayREACTOME_COMPLEMENT_CASCADE

IGLV7-43 IGLV6-57

2.29e-0311592M19752
PathwayREACTOME_PARASITE_INFECTION

IGLV7-43 IGLV6-57

2.33e-0311692M29843
PathwayREACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION

IGLV7-43 IGLV6-57

3.09e-0313492M29840
PathwayREACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION

IGLV7-43 IGLV6-57

3.18e-0313692M27207
PathwayREACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS

IGLV7-43 IGLV6-57

3.51e-0314392M27107
PathwayREACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS

IGLV7-43 IGLV6-57

4.06e-0315492M39007
PathwayREACTOME_REPRODUCTION

TOP3A ZP1

4.27e-0315892M26956
PathwayREACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR

IGLV7-43 IGLV6-57

4.70e-0316692M608
PathwayREACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING

IGLV7-43 IGLV6-57

5.87e-0318692M27175
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

IGLV7-43 IGLV6-57

6.11e-0319092M8240
PathwayREACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL

IGLV7-43 IGLV6-57

6.36e-0319492M16312
PathwayREACTOME_LEISHMANIA_INFECTION

IGLV7-43 IGLV6-57

8.05e-0321992M29836
Pubmed

Expanding the phenotypic spectrum of Mendelian connective tissue disorders to include prominent kidney phenotypes.

TGFBR1 FBN2

2.73e-07311234355836
Pubmed

Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.

TGFBR1 FBN2

5.45e-07411216835936
Pubmed

Heritable Thoracic Aortic Disease Overview

TGFBR1 FBN2

3.94e-053011220301299
Pubmed

Activation of C1r by proteolytic cleavage.

IGLV7-43 IGLV6-57

8.15e-05431121249422
Pubmed

Physicochemical and functional characterization of the C1r subunit of the first complement component.

IGLV7-43 IGLV6-57

9.75e-0547112814163
Pubmed

Recognition of immunoglobulins by Fcgamma receptors.

IGLV7-43 IGLV6-57

1.02e-044811211955599
Pubmed

Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development.

TGFBR1 FBN2

2.30e-047211237702066
Cytoband22q11.2

IGLV7-43 IGLV6-57

3.67e-0412011222q11.2
CytobandEnsembl 112 genes in cytogenetic band chr22q11

IGLV7-43 IGLV6-57

4.33e-03419112chr22q11
GeneFamilyImmunoglobulin lambda locus at 22q11.2

IGLV7-43 IGLV6-57

8.43e-048992353
CoexpressionHOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP

IGLV7-43 IGLV6-57

1.25e-0513112M41033
CoexpressionNABA_ECM_GLYCOPROTEINS

ZP1 USH2A FBN2

6.50e-05196113M3008
CoexpressionNABA_CORE_MATRISOME

ZP1 USH2A FBN2

1.77e-04275113M5884
CoexpressionSTAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN

ZP1 TGFBR1

2.02e-0451112M2102
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLPPR4 ZP1 FBN2

1.07e-05183113af8d86f15a549064530d94bd47081daf59d58ecd
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9

TGFBR1 FBN2

5.41e-0414311210955b54e4a87d035093a2756291ef1d6a14ab63
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

USH2A FBN2

5.64e-04146112c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

IGLV7-43 IGLV6-57

6.44e-04156112f0c4d9d58365b0ae8e10ba1aaf3847fb3f98c7ad
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USH2A FBN2

6.77e-04160112c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USH2A FBN2

6.77e-0416011225c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellPND03-Immune-Immune_Myeloid-DC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PLPPR4 ZP1

6.85e-04161112f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TGFBR1 USH2A

7.37e-04167112b0b2601c41c053b1caa6701ba2f5723e6059fb0a
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IGLV7-43 IGLV6-57

7.37e-04167112afb6d0993f3fd44a295874673055189d514f7b11
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLPPR4 USH2A

7.37e-04167112ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCelltumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass

IGLV7-43 IGLV6-57

7.54e-04169112b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCelldroplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLPPR4 USH2A

7.54e-04169112f00741203efa0b948db7223ee8c19bdd0918258a
ToppCellfacs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TOP3A ZP1

7.63e-04170112d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCellmetastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass

IGLV7-43 IGLV6-57

7.63e-0417011253634da9e9c72f6400639954c286c6e38ea5a188
ToppCelldroplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLPPR4 TGFBR1

7.72e-041711127ca404539344e14dcd90c746c9122f713a7db78b
ToppCelldroplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLPPR4 TGFBR1

7.72e-04171112ab113c8e773b0af47a87aed50e96be3ba71c3c82
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV7-43 IGLV6-57

7.90e-041731127e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EMSY TOP3A

8.18e-0417611291ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCelltumor_Lung-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass

IGLV7-43 IGLV6-57

8.18e-04176112683022c3400e951b26c2b49394dfd3cc415276fe
ToppCell5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLPPR4 FBN2

8.27e-04177112e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell10x5'-Liver-Lymphocytic_B_plasma-Plasmablasts|Liver / Manually curated celltypes from each tissue

IGLV7-43 IGLV6-57

8.27e-041771121d88ae316d65ca5fdc736c9da93885b6b40c32bb
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IGLV7-43 IGLV6-57

8.36e-0417811234ef4d36ddfb1cdeaaaf5d952e1ad6dc2785ce1e
ToppCellBAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IGLV7-43 IGLV6-57

8.55e-041801126a777a308fa3160d31eda468db930e71862020b2
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGLV7-43 IGLV6-57

8.55e-04180112cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCellmetastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass

PLPPR4 FBN2

8.64e-04181112bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IGLV7-43 IGLV6-57

8.64e-04181112768d14c452192f92fa557ae59e84c43436f575f0
ToppCellHealthy-B_memory|Healthy / disease group, cell group and cell class

IGLV7-43 IGLV6-57

8.64e-041811127b903076efb90026b9845af0c7a840901451193a
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

EMSY ZP1

8.83e-04183112a492b3827d2c368d33a7a5118748beaf4d7f6797
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USH2A FBN2

8.93e-04184112ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USH2A FBN2

8.93e-041841122cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USH2A FBN2

8.93e-041841122b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellControl-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class

TGFBR1 FBN2

9.12e-041861120bf16ac48931b62bb3c33d63ff4279654148e293
ToppCellFetal_brain|World / Sample Type, Dataset, Time_group, and Cell type.

PLPPR4 EMSY

9.42e-04189112643abc3c0afe1d3711b49bb5c1ab5951675884ad
ToppCellControl-Myeloid-MoAM3,_VCAN|Control / Condition, Lineage and Cell class

TGFBR1 FBN2

9.62e-0419111276c2fbc62855a65600cd6b8dd1e2d2c3d7415921
ToppCellPCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung

TGFBR1 FBN2

9.92e-041941125759c83308df017f1faae248e9b85388e25254f0
ToppCellCOVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass

IGLV7-43 IGLV6-57

1.01e-03196112026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IGLV7-43 IGLV6-57

1.01e-03196112fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCellCOVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

IGLV7-43 IGLV6-57

1.02e-03197112fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
DrugTAAD

TGFBR1 FBN2

2.91e-052192CID000133445
DrugFluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; PC3; HT_HG-U133A

EMSY TOP3A FBN2

4.85e-05193936691_DN
DrugD-cycloserine [68-41-7]; Down 200; 39.2uM; HL60; HT_HG-U133A

EMSY TOP3A TGFBR1

5.16e-05197936139_DN
DrugAmidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A

PLPPR4 EMSY FBN2

5.24e-05198932060_UP
DrugTops

TOP3A FBN2

9.69e-053892CID000169814
Drugfuniferine N-oxide

TOP3A FBN2

1.62e-044992CID000191631
Drugp-acetaminobenzaldehyde thiosemicarbazone

TOP3A FBN2

2.35e-045992CID002733749
Drugcinnamoate

FBN2 KRT38

3.31e-047092CID000008784
DrugSalisorosides Rosavin

TOP3A FBN2

3.40e-047192CID003340349
Drugbu-b

USH2A FBN2

4.00e-047792CID000351065
Drugcephadroxil

TOP3A FBN2

4.99e-048692CID000002610
DrugAC1MPJID

TOP3A FBN2

9.21e-0411792CID003386230
Drughomocysteine thiolactone

FBN2 KRT38

1.15e-0313192CID000107712
DrugDFMO

TOP3A FBN2

1.61e-0315592CID000003009
Drugal-Badry

TOP3A KRT38

1.82e-0316592CID000004545
DrugLycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A

EMSY TOP3A

1.88e-03168924365_UP
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

EMSY FBN2

2.23e-03183921206_UP
DrugF0447-0125; Down 200; 10uM; PC3; HT_HG-U133A

TOP3A FBN2

2.25e-03184926429_DN
DrugProtriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

PLPPR4 FBN2

2.33e-03187925438_UP
DrugOxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A

EMSY TOP3A

2.42e-03191924124_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

EMSY TOP3A

2.42e-03191925581_DN
DrugDipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A

TOP3A TGFBR1

2.45e-03192923929_DN
DrugSTOCK1N-35215; Down 200; 10uM; MCF7; HT_HG-U133A

EMSY TOP3A

2.47e-03193926422_DN
DrugPrednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A

EMSY TOP3A

2.47e-03193925119_DN
DrugEthopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A

EMSY TOP3A

2.47e-03193926697_DN
DrugIsoflupredone acetate [338-98-7]; Down 200; 9.6uM; HL60; HT_HG-U133A

EMSY TOP3A

2.47e-03193921873_DN
DrugPrazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A

EMSY TOP3A

2.47e-03193923098_DN
DrugSimvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A

TOP3A TGFBR1

2.50e-03194924828_UP
DrugIohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A

PLPPR4 TOP3A

2.50e-03194924643_UP
DrugBetazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A

EMSY FBN2

2.50e-03194921812_UP
DrugNorcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A

TOP3A FBN2

2.50e-03194922469_DN
DrugOxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A

PLPPR4 FBN2

2.50e-03194924246_DN
DrugSertaconazole nitrate [99592-39-9]; Down 200; 8uM; HL60; HT_HG-U133A

TOP3A TGFBR1

2.50e-03194926128_DN
DrugCinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A

EMSY TOP3A

2.50e-03194924107_DN
DrugDirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A

EMSY TOP3A

2.50e-03194927446_DN
DrugQuinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A

EMSY TOP3A

2.50e-03194924529_DN
DrugHarmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A

TOP3A FBN2

2.50e-03194925855_UP
DiseaseFamilial thoracic aortic aneurysm and aortic dissection

TGFBR1 FBN2

1.13e-045392C4707243
Diseaserespiratory system disease

EMSY TGFBR1

8.44e-0414592EFO_0000684
DiseaseColorectal Neoplasms

TGFBR1 FBN2

3.03e-0327792C0009404
Diseasemean arterial pressure

TOP3A FBN2

9.50e-0349992EFO_0006340

Protein segments in the cluster

PeptideGeneStartEntry
TTCGPTCGASTTGSR

KRT38

441

O76015
ESPGKTVTISCTGSS

IGLV6-57

31

P01721
VSPGGTVTLTCASST

IGLV7-43

31

P04211
KCRESCSSPSTVGSS

EMSY

1206

Q7Z589
TCSSGQISSTCGSKS

FBN2

131

P35556
CTSGGCSTSKPTSIT

USH2A

4336

O75445
CAPSSKTGSVTTTYC

TGFBR1

86

P36897
SSPKNTEGSTVSCTG

PLPPR4

591

Q7Z2D5
TSGLETCSTACSTGT

ZP1

536

P60852
SGSGTSCLCSQPSVT

TOP3A

891

Q13472
VSKSTSTSEPTTGCS

ZNF280C

721

Q8ND82